Refine your search
Collections
Journals
Year
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All
Agiwal, Paresh Shirish
- Study of Serum Alkaline Phosphatase Levels among Psoriasis Patients and Comparative Group in Tertiary Care Institute
Abstract Views :162 |
PDF Views:114
Authors
Affiliations
1 Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital & RC, Nashik – 422003, Maharashtra, IN
1 Department of Dermatology, Dr. Vasantrao Pawar Medical College Hospital & RC, Nashik – 422003, Maharashtra, IN
Source
MVP Journal of Medical Sciences, Vol 5, No 2 (2018), Pagination: 211-215Abstract
Background: Psoriasis is a chronic relapsing autoimmune skin disease of unknown etiology, characterised by complex alterations in epidermal growth and differentiation. Oxidative stress is a known risk factor for exacerbation of psoriasis. Serum alkaline phosphatase level is a marker of oxidative stress in body. Aims and Objectives: To study and compare serum alkaline phosphatase levels in cases of psoriasis. Materials and Methods: Serum Alkaline Phosphatase levels were evaluated in 100 cases of psoriasis and controls. Results: There was no statistically significant difference between serum alkaline phosphatase levels among cases and controls. Conclusion: Serum alkaline phosphatase levels, as a marker of oxidative stress is not significantly raised in cases of psoriasis.Keywords
Alkaline Phosphatase, Oxidative Stress, Psoriasis.Full Text
References
- Nickoloff BJ, Nestle FO. Recent insights into the immunopathogenesis of psoriasis provide new therapeutic opportunities, J. Clin. Invest. 2004; 113:1664−75.
- Dogra S, Yadav S. Psoriasis in India: Prevalence and pattern, Indian J. Dermatol. Venerol. Leprol. 2010; 76:595−601.
- Bedi TR. Clinical profile of psoriasis in North India, Indian J. Dermatol. Venereol. Leprol. 1995; 61:202−5.
- Kaur I, Handa S, Kumar B. Natural history of psoriasis: A study from the Indian subcontinent, J. Dermatol. 1997; 24:230−4.
- Malligarjunan H, Gnanaraj P, Subramanian S, Elango T, Dayalan H. Clinical efficacy of propylthiouracil and its influence on prolactin in psoriatic patients, Clin. Biochem. 2011 Oct; 44(14-15):1209−13. Epub. 2011 Jul 28. https://doi.org/10.1016/j.clinbiochem.2011.07.009.
- Smith AE, Kassab JY, Rowland Payne CME, Beur WE. Bimodality in age of onset of psoriasis in both patients and relatives, Dermatology. 1993; 186:181−86.
- Pavithran K, Karunakaran M, Aparna P, Raghunatha S. PsoariasisIn: Valia RG, Valia AR. EDS. Disorders of keratinization. IADVL textbook of dermatology. Third edition. Volume 1, reprint. Bhalani publishing house; 2012. 30, p. 1021−56.
- Gudjonsson JE, Elder JT. Psoriasis. In: Goldsmith LA, Katz SI, Gilchrest, Paller AS, Leffell DJ, Wolff K. Eds. Fitzpatrick Dermatology in General Medicine. Eighth edition. Volume I; 2008. 18, p. 197−231.
- Griffiths CEM, Barker JNWN. Psoriasis In: Tony B, Stephen B, Neil C, Christopher G. editors. Rook textbook of dermatology, Eighth edition. Volume 1, Wiley-Blackwell; 2010. 20, p. 1−20.
- Peter Cm, Kerkhof vd, Nestle FO. Psoriasis In: Bolognia JL, Jorizzo JL, Schaffer JV, Eds. Dermatology, Third edition. Elsevier; 2008. p. 135−56.
- Smith CH, Anstey AV, Barker JN et al. British Association of Dermatologists guidelines for use of biological intervention in psoriasis, Br J Dermatol. 2005; 153:486−97.
- David H. Vroon, Zafar Israili. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd Edition.
- Oxidative Medicine and Cellular Longevity. 2016 (2016). Article ID 8490643, p. 7.
- Bhatnagar M, Bapna A, Khare A K. Serum proteins, trace metals and phosphatases in psoriasis, Indian J. DermatolVenereol. Leprol. 1994; 60:18−2
- Franck H, Ittel T. Serum osteocalcin levels in patients with psoriatic arthritis: An extended report, Rheumatol Int. 2000; 19(5):161−4
- Nestle FO et al. Skin immune sentinels in health and disease, Nat. Rev. Immunol. 2009; 9(10):679−91.
- Sheikh G, Masood Q, Majeed S, Hassan I. Comparison of levels of serum copper, zinc, albumin, globulin and alkaline phosphatase in psoriatic patients and controls: A hospital based case control study, Indian Dermatol. Online J. 2015 Mar-Apr; 6(2):81−3. https://doi.org/10.4103/2229-5178.153006.
- Enerback C, Martinsson T, Inerot A, Wahlstrom J, Enlund F, Yhr M, Swanbeck G. Evidence that HLA-cw6 determines early onset of psoriasis, obtained using sequence-specific primers (PCR-SSP), Acta. Dermatovenerologica. 1997; 77(4):273−76.
- Cohen A D, Gilutz H, Henkin Y, Zahger D, Shapiro J, Bonneh D Y, Vardy D A. Psoriasis and the Metabolic Syndrome. ActaDermVenereol 2007; 87: 506–509. https://doi.org/10.2340/00015555-0297.
- Madanagobalane S, Anandan S. Prevalence of metabolic syndrome in south Indian patients with psoriasis vulgar is and the relation between disease severity and metabolic syndrome: A hospital-based case-control study, Indian J. Dermatol. 2012; 57:353−7.
- Golov KG, Varshavskiĭ VA, OkunevDIu, Neverov NI, Shestakova MV, Proskurneva FP. Urinary enzymes in the assessment of the early stage of kidney involvement in psoriasis and diabetes mellitus, Ter. Arkh. 1995; 67(10):80−1 (Russian).
- McMillan EM, Rowe D. Plasma zinc in psoriasis: relation to surface area involvement, Br. J. Dermatol. 1983 Mar; 108(3):301−05. PubMed PMID: 6830695.